Did you know?

Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry.PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8th, 2023. Company management will host a conference call to discuss financial results at 5:00PM ET.Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $57,536 on 31 March 2023.3,990 units of CERT stock worth $57,536 on 31 March 2023.Oct 4, 2021 · At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA. Download Version 8.4. Reach Your Professional Development Goals. Certara University provides on-demand and on-site courses. Our programs are designed for novice and advanced users in the area of pharmacokinetic (PK) and pharmacodynamics (PD) and are taught using Certara software including the industry-standard software Phoenix …November 17, 2021. PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf ... - Certara - Investor Tools. Print Page. Email Alerts ...Principal Financial Group Inc. lowered its stake in shares of Certara, Inc. (NASDAQ:CERT – Free Report) by 5.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 600,624 shares of the company’s stock after selling 36,064 …According to the issued ratings of 15 analysts in the last year, the consensus rating for Devon Energy stock is Moderate Buy based on the current 6 hold ratings, 8 buy ratings and 1 strong buy rating for DVN. The average twelve-month price prediction for Devon Energy is $57.82 with a high price target of $77.00 and a low price target of $48.00.PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the …Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Certara Inc stock has a Value Score of 15, Momentum Score of 49 and Estimate Revisions Score of 29. Comparing Samsara Inc and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.About Certara Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at Certara.com. Certara Contact:Dec 1, 2023 · 8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price. William Blair Investment Management LLC grew its position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) by 4.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,026,786 shares of the company's sThe estimated Net Worth of William F Feehery is at least $74.9 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $41,776,274 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.November 17, 2021. PRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.Download Version 8.4. Reach Your Professional Development Goals. Ce5 brokerages have issued 1-year price objectives f Nov 10, 2023 · Certara Inc’s Stock Price as of Market Close. As of November 10, 2023, 4:00 PM, CST, Certara Inc’s stock price was $13.50. Certara Inc is up 6.72% from its previous closing price of $12.65. During the last market session, Certara Inc’s stock traded between $12.61 and $13.36. Currently, there are 159.17 million shares of Certara Inc stock ... William Blair Investment Management LLC grew its position Certara Price Performance. CERT stock opened at $14.64 on Friday. The company has a quick ratio of 3.51, a current ratio of 3.51 and a debt-to-equity ratio of 0.27. The business has a 50 day ... Dr Feehery owns over 36,580 units of Certara stock worth over $42,5

Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Certara, Inc. (NASDAQ:CERT – Get Free Report) was the target of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 4,690,000 shares, a ...OPGN | Complete OpGen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $54,863 on 31 March 2023.3,990 units of CERT stock worth $54,863 on 31 March 2023.

7 Nov 2022 ... Certara shares soar after Arsenal buys back EQT's stake · Arsenal says it will acquire roughly 30 million shares at $15 per share, reflecting a ...Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …The company had revenue of $85.58 million for the quarter, compared to analyst estimates of $85.96 million. Certara has generated ($0.21) earnings per share over the last year (($0.21) diluted earnings per share). Earnings for Certara are expected to decrease by -9.09% in the coming year, from $0.33 to $0.30 per share.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. CERT Certara, Inc. Stock Price & Overvi. Possible cause: Biosimulation can reduce the size of and cost of human trials, the most expensive and tim.